On July 11, Ustar Biotechnologies (Hangzhou)
Ltd successfully obtained the IVDR CE certificates issued by TÜV SÜD, which
covers the company's first 10 products. This
marks an important breakthrough for the company in the field of in vitro
diagnostic medical devices, further consolidating its competitive advantage in
the EU market.